Telbivudine therapy may shape CD4+ T‐cell response to prevent liver fibrosis in patients with chronic hepatitis B

Publisher: John Wiley & Sons Inc

E-ISSN: 1478-3231|35|3|834-845

ISSN: 1478-3223

Source: LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.3, 2015-03, pp. : 834-845

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract